The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Aspirin in the prevention of pre‐eclampsia in high‐risk women: a randomised placebo‐controlled PREDO Trial and a meta‐analysis of randomised trials
Abstract
Objective To study the effect of aspirin in the prevention of pre‐eclampsia in high‐risk women. Design Randomised, double‐blinded, placebo‐controlled trial. Setting Maternity clinics in ten Finnish hospitals participating in the PREDO Project. Sample A total of 152 women with risk factors for pre‐eclampsia and abnormal uterine artery Doppler velocimetry. Methods Participants were randomised to start either aspirin 100 mg/day or placebo at 12 + 0 to 13 + 6 weeks + days of gestation. Because of the limited power of this trial, we also conducted a meta‐analysis of randomised controlled trials that included data on 346 women with abnormal uterine artery Doppler flow velocimetry, and aspirin 50–150 mg/day started at or before 16 weeks of gestation. Main outcome measure Pre‐eclampsia, gestational hypertension and birthweight standard deviation (SD) score. Outcome measures for the meta‐analysis were pre‐eclampsia, severe pre‐eclampsia, preterm (diagnosed <37 + 0 weeks of gestation) and term pre‐eclampsia. Results From the 152 randomised women, 121 were included in the final analysis. Low‐dose aspirin did not reduce the rate of pre‐eclampsia (relative risk [RR] 0.7, 95% CI 0.3–1.7); gestational hypertension (RR 1.6, 95% CI 0.6–4.2); early‐onset pre‐eclampsia (diagnosed <34 + 0 weeks of gestation) (RR 0.2, 95% CI 0.03–2.1); or severe pre‐eclampsia (RR 0.4, 95% CI 0.1–1.3); and the results were not statistically significant in an intention‐to‐treat analysis. However, our meta‐analysis, including the current data, suggested that low‐dose aspirin initiated before 16 weeks of gestation reduces the risk of pre‐eclampsia (RR 0.6, 95% CI 0.4–0.8) and severe pre‐eclampsia (RR 0.3, 95% CI 0.1–0.7). Conclusions Our trial showed no statistically significant effect of aspirin in preventing pre‐eclampsia in high‐risk women. However, our meta‐analysis suggested that aspirin may reduce the incidence of pre‐eclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KHONG, T. Y., DE WOLF, F., ROBERTSON, W. B., & BROSENS, I. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07830.x · Cited by 1,591
Cited by
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Henderson, J. T., Whitlock, E. P., O’Connor, E., Senger, C. A., Thompson, J. H., & Rowland, M. G. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2844 · Cited by 499
Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis
Roberge, S., Nicolaides, K. H., Demers, S., Villa, P., & Bujold, E. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.12421 · Cited by 391
Self-citationAntiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Meher, S., Hunter, K. E., Seidler, A. L., & Askie, L. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub3 · Cited by 366
Metadata
- Authors
- Villa, P., Kajantie, E., Räikkönen, K., Pesonen, A., Hämäläinen, E., Vainio, M., Taipale, P., Laivuori, H., & on behalf of the PREDO Study group
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 2012-11-06
- Volume
- 120
- Issue
- 1
- Pages
- 64-74
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- OpenAlex
- W1580167980
- Cited by
- 180
- References
- 1
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aspirin in the prevention of pre‐eclampsia in high‐risk women: a randomised placebo‐controlled PREDO Trial and a meta‐analysis of randomised trials. https://app.cochat.ai/papers/10.1111/j.1471-0528.2012.03493.x
- The paper
- Villa, P., Kajantie, E., Räikkönen, K., Pesonen, A., Hämäläinen, E., Vainio, M., Taipale, P., Laivuori, H., & on behalf of the PREDO Study group. (2013). Aspirin in the prevention of pre‐eclampsia in high‐risk women: a randomised placebo‐controlled PREDO Trial and a meta‐analysis of randomised trials. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.2012.03493.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.